Back to results
US 8,569,503 B2Granted
Processes and intermediates for preparing fused heterocyclic kinase inhibitors
AssigneeMethylGene Inc.
InventorLjubomir Isakovic
Life of this patent
Estimating the term…
Abstract
This invention relates to processes and intermediates for manufacturing fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, and to processes and intermediates for preparing intermediates that are useful in the manufacture of fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, particularly at an industrial level.
Claims1
A compound having the structure:
Dependencies are inferred from the claim text.